Physician profile
Ross I Bederman
NPI 1942573704
$2,451.43
in general payments reported to CMS, 2019-2025
10 companies · $31.60 in 2025
The $31.60 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,500 · 2022: $13.26 · 2023: $74.78 · 2024: $832 · 2025: $31.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $675 · Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $675.00 |
| Food and Beverage | $263.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Zimvie INC. | $775.68 | 2024 | |
| Voco America INC. | $30.61 | 2023-2025 | Futurabond U, Admira Fusion X-Tra, Bifix Temp |
| Nobel Biocare USA | $29.37 | 2023 | Nobelactive |
| Kerr Corporation | $29.36 | 2023 | Harmonize |
| Align Technology, INC. | $22.13 | 2024 | Invisalign |
| Dentsply Sirona INC | $20.86 | 2024 | Surefil Sdr Flow+ Bulk Fill Flowable |
| Kulzer, LLC | $17.04 | 2025 | |
| Straumann USA LLC | $13.26 | 2022 | |
| Solventum Corporation | $13.12 | 2024 | 3m Scotchbond, 3m Filtek, Paradigm Temporization |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Bederman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.